Feb 06, 2024 / 08:30AM GMTOperator Ladies and gentlemen, good day and welcome to Q3-FY24 result conference call of Vaishali Pharma Limited hosted by Kirin Advis
Vaishali Pharma's board approved a 1:5 stock split and a 1:1 bonus share issue, causing the stock to surge 10% to Rs 190.35 on the NSE. The split, pending shareholder and regulatory approvals, will be given to eligible shareholders as on record date which will be announced later.